High Glucose Promotes Epithelial-Mesenchymal Transition, Migration and Invasion in A20 Murine Diﬀuse Large B-Cell Lymphoma Cells Through Increased Expression of High Mobility Group AT-Hook 2 (HMGA2)

Overview

Journal Med Sci Monit

Specialties General Medicine
Pathology

Date 2019 May 25

PMID 31124542

Citations 2

Authors

Ya Wang

Jie Tan

Hongyan Wu

Cunjian Yi

Affiliations

Soon will be listed here.

Abstract

BACKGROUND Patients with type 2 diabetes mellitus have been reported to be at increased risk of developing non-Hodgkin's lymphoma (NHL). Diffuse large B-cell lymphoma (DLBCL) is the most common type of high-grade NHL. This study aimed to investigate the effects of high glucose on cell migration, invasion and epithelial-mesenchymal transition (EMT), and the expression of high mobility group AT-hook 2 (HMGA2) in A20 murine DLBCL cells. MATERIAL AND METHODS Quantitative real-time polymerase chain reaction (qRT-PCR) and Western blot were used to analyze the expression of HMGA2 at the gene and protein level and EMT markers in the A20 murine DLBCL cell line. A transwell assay evaluated cell migration and invasion of A20 cells. Short-interfering RNA (siRNA) was used to knockdown HMGA2 expression. RESULTS High glucose levels upregulated the expression of HMGA2, induced phenotypic changes of EMT, and increased cell migration and invasion in A20 cells. Knockdown of HMGA2 by siRNA effectively inhibited EMT induced by high glucose in A20 cells by directly regulating the Wnt/ß-catenin signaling pathway. CONCLUSIONS In the A20 murine DLBCL cell line, high glucose upregulated the expression of HMGA2 to induce EMT and promote cell migration and invasion through the Wnt/ß-catenin signaling pathway.

Citing Articles

EZB-type diffuse large B-cell lymphoma cell lines have superior migration capabilities compared to MCD-type.

Sherif M, Schafer H, Scharf S, van Oostendorp V, Sadeghi Shoreh Deli A, Loth A Br J Haematol. 2024; 205(6):2327-2337.

PMID: 39355919 PMC: 11637725. DOI: 10.1111/bjh.19778.

HMGA Genes and Proteins in Development and Evolution.

Vignali R, Marracci S Int J Mol Sci. 2020; 21(2).

PMID: 31963852 PMC: 7013770. DOI: 10.3390/ijms21020654.

References

Odero M, Grand F, Iqbal S, Ross F, Roman J, Vizmanos J . Disruption and aberrant expression of HMGA2 as a consequence of diverse chromosomal translocations in myeloid malignancies. Leukemia. 2004; 19(2):245-52. DOI: 10.1038/sj.leu.2403605. View

Cleynen I, Van de Ven W . The HMGA proteins: a myriad of functions (Review). Int J Oncol. 2008; 32(2):289-305. View

Wang W, Xue L, Wang P . Prognostic value of β-catenin, c-myc, and cyclin D1 expressions in patients with esophageal squamous cell carcinoma. Med Oncol. 2010; 28(1):163-9. DOI: 10.1007/s12032-010-9436-0. View

Joetzke A, Sterenczak K, Eberle N, Wagner S, Soller J, Nolte I . Expression of the high mobility group A1 (HMGA1) and A2 (HMGA2) genes in canine lymphoma: analysis of 23 cases and comparison to control cases. Vet Comp Oncol. 2010; 8(2):87-95. DOI: 10.1111/j.1476-5829.2010.00207.x. View

Lemma S, Karihtala P, Haapasaari K, Jantunen E, Soini Y, Bloigu R . Biological roles and prognostic values of the epithelial-mesenchymal transition-mediating transcription factors Twist, ZEB1 and Slug in diffuse large B-cell lymphoma. Histopathology. 2012; 62(2):326-33. DOI: 10.1111/his.12000. View

Baecklund E, Smedby K, Sutton L, Askling J, Rosenquist R . Lymphoma development in patients with autoimmune and inflammatory disorders--what are the driving forces?. Semin Cancer Biol. 2013; 24:61-70. DOI: 10.1016/j.semcancer.2013.12.001. View

Duan W, Shen X, Lei J, Xu Q, Yu Y, Li R . Hyperglycemia, a neglected factor during cancer progression. Biomed Res Int. 2014; 2014:461917. PMC: 4016871. DOI: 10.1155/2014/461917. View

Zhang J, Luo J, Liu F, Wu D, Zhong Q, Zeng L . Diabetes mellitus potentiates diffuse large B‑cell lymphoma via high levels of CCL5. Mol Med Rep. 2014; 10(3):1231-6. DOI: 10.3892/mmr.2014.2341. View

Yang W, Li H, Xu H, Yang G, Gao Y, Zheng W . Type 2 diabetes and the risk of non-Hodgkin's lymphoma: a report from two population-based cohort studies in China. Eur J Cancer Prev. 2015; 25(2):149-54. PMC: 4575595. DOI: 10.1097/CEJ.0000000000000150. View

10.

Joshi S, Liu M, Turner N . Diabetes and its link with cancer: providing the fuel and spark to launch an aggressive growth regime. Biomed Res Int. 2015; 2015:390863. PMC: 4413255. DOI: 10.1155/2015/390863. View

11.

Xia Y, Yin L, Jiang N, Guo W, Tian H, Jiang X . Downregulating HMGA2 attenuates epithelial-mesenchymal transition-induced invasion and migration in nasopharyngeal cancer cells. Biochem Biophys Res Commun. 2015; 463(3):357-63. DOI: 10.1016/j.bbrc.2015.05.068. View

12.

Han J, Zhang L, Guo H, Wysham W, Roque D, Willson A . Glucose promotes cell proliferation, glucose uptake and invasion in endometrial cancer cells via AMPK/mTOR/S6 and MAPK signaling. Gynecol Oncol. 2015; 138(3):668-75. PMC: 4672629. DOI: 10.1016/j.ygyno.2015.06.036. View

13.

Vrachnis N, Iavazzo C, Iliodromiti Z, Sifakis S, Alexandrou A, Siristatidis C . Diabetes mellitus and gynecologic cancer: molecular mechanisms, epidemiological, clinical and prognostic perspectives. Arch Gynecol Obstet. 2015; 293(2):239-46. DOI: 10.1007/s00404-015-3858-z. View

14.

Shi Z, Li X, Wu D, Tang R, Chen R, Xue S . Silencing of HMGA2 suppresses cellular proliferation, migration, invasion, and epithelial-mesenchymal transition in bladder cancer. Tumour Biol. 2015; 37(6):7515-23. DOI: 10.1007/s13277-015-4625-2. View

15.

Flores-Lopez L, Martinez-Hernandez M, Viedma-Rodriguez R, Diaz-Flores M, Baiza-Gutman L . High glucose and insulin enhance uPA expression, ROS formation and invasiveness in breast cancer-derived cells. Cell Oncol (Dordr). 2016; 39(4):365-78. DOI: 10.1007/s13402-016-0282-8. View

16.

Li W, Zhang L, Chen X, Jiang Z, Zong L, Ma Q . Hyperglycemia Promotes the Epithelial-Mesenchymal Transition of Pancreatic Cancer via Hydrogen Peroxide. Oxid Med Cell Longev. 2016; 2016:5190314. PMC: 4940572. DOI: 10.1155/2016/5190314. View

17.

Li W, Wang Z, Zha L, Kong D, Liao G, Li H . HMGA2 regulates epithelial-mesenchymal transition and the acquisition of tumor stem cell properties through TWIST1 in gastric cancer. Oncol Rep. 2016; 37(1):185-192. DOI: 10.3892/or.2016.5255. View

18.

Chang S, Yang W . Hyperglycemia, tumorigenesis, and chronic inflammation. Crit Rev Oncol Hematol. 2016; 108:146-153. DOI: 10.1016/j.critrevonc.2016.11.003. View

19.

Santamaria P, Moreno-Bueno G, Portillo F, Cano A . EMT: Present and future in clinical oncology. Mol Oncol. 2017; 11(7):718-738. PMC: 5496494. DOI: 10.1002/1878-0261.12091. View

20.

Huang R, Zong X . Aberrant cancer metabolism in epithelial-mesenchymal transition and cancer metastasis: Mechanisms in cancer progression. Crit Rev Oncol Hematol. 2017; 115:13-22. DOI: 10.1016/j.critrevonc.2017.04.005. View